Asahi Intecc USA News and Activities

Asahi Intecc USA is owned by Asahi Intecc.

Asahi Intecc is one of the...

• TOB Iconic 10,000;
• Topix.

Asahi Intecc is a company listed under the stock ticker 7747 (JP).

Asahi Intecc has a direct presence in 2 countries.

They are in:

• Electrical & Electronic Components50%
• Biotechnology50%

View the org chart displaying its 3 main executives

Most searched biographies at Asahi Intecc USA

• Michael Luk, Senior Director, Front End Innovation
• David Zivkovic, Vice President of Sales
• Jim Dinkel, Vice President, Medical Sales & Marketing

Create your alert
to follow the executive moves at Asahi Intecc USA.

Asahi Intecc has 2,426 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Clearside Biomedical has gone out of its bankruptcy protection  (posted on July 15 2026).
• Attovia Therapeutics has filed its IPO. Its stock ticker will be ATTO. (posted on July 15 2026).
• The new name of ChemoTech is Neem’s Hill. (posted on July 15 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Asahi Intecc USA

Social media about Asahi Intecc USA

• Asahi Intecc USA on Wikipedia, Google News & Yahoo Finance
• Asahi Intecc USA on LinkedIn, X (Twitter) & YouTube